Tolcapone

Last Updated: 11/08/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 571 publications

Modulatory effects of α7-nicotinic cholinergic receptors on perceptual sensitivity in a visual signal detection task.

Modulatory effects of α7-nicotinic cholinergic receptors on perceptual sensitivity in a visual signal detection task.

Journal: Psychopharmacology

Published: May 18, 2026

Case Report: Five-year follow-up of leptomeningeal transthyretin amyloidosis (Ala45Thr) with CNS involvement under tolcapone therapy.

Case Report: Five-year follow-up of leptomeningeal transthyretin amyloidosis (Ala45Thr) with CNS involvement under tolcapone therapy.

Journal: Frontiers in medicine

Published: April 11, 2026

Beyond β-amyloid: transthyretin cerebral amyloid angiopathy.

Beyond β-amyloid: transthyretin cerebral amyloid angiopathy.

Journal: Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology

Published: April 08, 2026

The therapeutic potential of COMT inhibition: cognition and beyond.

The therapeutic potential of COMT inhibition: cognition and beyond.

Journal: Molecular psychiatry

Published: March 24, 2026

Repurposed catechol-O-methyltransferase inhibitors tolcapone and entacapone preferentially suppress aggregation and seeding of P301 mutant tau in human neuronal models.

Repurposed catechol-O-methyltransferase inhibitors tolcapone and entacapone preferentially suppress aggregation and seeding of P301 mutant tau in human neuronal models.

Journal: British journal of pharmacology

Published: March 14, 2026

Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation.

Dopamine-Enhancing Therapies and Risk of Neovascular AMD Conversion: A Target Trial Emulation.

Journal: American journal of ophthalmology

Published: March 10, 2026

Tolcapone-loaded nanostructured lipid carriers for improved oral delivery.

Tolcapone-loaded nanostructured lipid carriers for improved oral delivery.

Journal: International journal of pharmaceutics

Published: November 25, 2025

Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson's disease: a Bayesian network meta-analysis.

Efficacy of MAO-B and COMT inhibitors on quality of life in patients with Parkinson's disease: a Bayesian network meta-analysis.

Journal: Frontiers in neurology

Published: November 24, 2025

Consensus Molecules Associated with Parkinson's Disease.

Consensus Molecules Associated with Parkinson's Disease.

Journal: Neurology international

Published: November 20, 2025

Venlafaxine upregulates cortical catechol-O-methyltransferase expression and activity in rats and mice.

Venlafaxine upregulates cortical catechol-O-methyltransferase expression and activity in rats and mice.

Journal: Drug metabolism and disposition: the biological fate of chemicals

Published: November 05, 2025

Tolcapone Interferes With Key Pathological Features in Alzheimer's Disease.

Tolcapone Interferes With Key Pathological Features in Alzheimer's Disease.

Journal: Bioinorganic chemistry and applications

Published: August 26, 2025

The Seminal Role of the Proinflammatory Cytokine IL-1β and Its Signaling Cascade in Glioblastoma Pathogenesis and the Therapeutic Effect of Interleukin-1β Receptor Antagonist (IL-1RA) and Tolcapone.

The Seminal Role of the Proinflammatory Cytokine IL-1β and Its Signaling Cascade in Glioblastoma Pathogenesis and the Therapeutic Effect of Interleukin-1β Receptor Antagonist (IL-1RA) and Tolcapone.

Journal: International journal of molecular sciences

Published: June 25, 2025

Showing 1-12 of 571

Last Updated: 11/08/2026